1. Li, Qing, Chen, Leifeng, Luo, Chen, Liu, Xiuxia, Yuan, Rongfa. 2020. TAB3 upregulates PIM1 expression by directly activating the TAK1-STAT3 complex to promote colorectal cancer growth. In Experimental cell research, 391, 111975. doi:10.1016/j.yexcr.2020.111975. https://pubmed.ncbi.nlm.nih.gov/32229191/
2. Zhao, Jiyi, Gai, Ling, Gao, Yi, Liu, Pengfei, Chen, Jie. 2018. TAB3 promotes human esophageal squamous cell carcinoma proliferation and invasion via the NF‑κB pathway. In Oncology reports, 40, 2876-2885. doi:10.3892/or.2018.6686. https://pubmed.ncbi.nlm.nih.gov/30226617/
3. Roshan-Milani, Shiva, Sattari, Parisa, Ghaderi-Pakdel, Firouz, Naderi, Roya. 2022. miR-23b/TAB3/NF-κB/p53 axis is involved in hippocampus injury induced by cerebral ischemia-reperfusion in rats: The protective effect of chlorogenic acid. In BioFactors (Oxford, England), 48, 908-917. doi:10.1002/biof.1830. https://pubmed.ncbi.nlm.nih.gov/35201648/
4. Xie, Lina, Liu, Siyang, Zhang, Yong, Song, Xiyue, Cao, Shuanghe. 2023. Efficient proteome-wide identification of transcription factors targeting Glu-1: A case study for functional validation of TaB3-2A1 in wheat. In Plant biotechnology journal, 21, 1952-1965. doi:10.1111/pbi.14103. https://pubmed.ncbi.nlm.nih.gov/37381172/
5. Li, Y-L, Zhang, X-X, Yao, J-N, Zhou, H-N, Zhang, L-F. . ZEB2-AS1 regulates the expression of TAB3 and promotes the development of colon cancer by adsorbing microRNA-188. In European review for medical and pharmacological sciences, 24, 4180-4189. doi:10.26355/eurrev_202004_20998. https://pubmed.ncbi.nlm.nih.gov/32373954/
6. Chen, Yannan, Wang, Xia, Duan, Chengwei, Wang, Wei, Xi, Qinghua. 2016. Loss of TAB3 expression by shRNA exhibits suppressive bioactivity and increased chemical sensitivity of ovarian cancer cell lines via the NF-κB pathway. In Cell proliferation, 49, 657-668. doi:10.1111/cpr.12293. https://pubmed.ncbi.nlm.nih.gov/27651027/
7. Ishitani, Tohru, Takaesu, Giichi, Ninomiya-Tsuji, Jun, Gaynor, Richard B, Matsumoto, Kunihiro. . Role of the TAB2-related protein TAB3 in IL-1 and TNF signaling. In The EMBO journal, 22, 6277-88. doi:. https://pubmed.ncbi.nlm.nih.gov/14633987/